Eli Lilly, Pfizer Stocks Rise After Trump’s 100% Pharma Tariff Threat. Here’s Why.
1. Trump announced 100% tariffs on imported branded drugs unless U.S. manufacturing occurs. 2. Despite tariffs, U.S. pharma stocks like LLY rose early in trading. 3. Uncertainty remains regarding tariff details and potential legal challenges. 4. Investors perceive more bark than bite from policy changes. 5. Smaller biotechs may face negative impacts from tariffs.